pteridines has been researched along with vorinostat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Carducci, MA; Gonzalez, M; Hammers, H; Kachhap, SK; Kaelber, NS; Kim, E; Kortenhorst, MS; Mendonca, J; van Diest, PJ; Wissing, MD | 1 |
Gohda, J; Inoue, JI; Ishida, T; Kawaguchi, Y; Liu, K; Suzuki, K; Takeuchi, H; Xie, X | 1 |
Acikelli, AH; Andrioff, S; D'Souza, F; Dammann, P; Demmig, R; Díaz-Carballo, D; Erwes, J; Grandi, N; Homp, E; Klein, D; Klein, J; Malak, S; Menze, S; Nasreen, A; Noa-Bolaño, A; Ochsenfarth, C; Pano, E; Saka, S; Schröer, K; Strumberg, D; Tannapfel, A; Teipel, M; Tramontano, E | 1 |
3 other study(ies) available for pteridines and vorinostat
Article | Year |
---|---|
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Polo-Like Kinase 1; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Valproic Acid; Vorinostat | 2013 |
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1.
Topics: Cell Line, Tumor; Drug Combinations; Gene Expression Regulation, Viral; Histone Deacetylase Inhibitors; HIV-1; Host-Pathogen Interactions; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lymphocytes; Monocytes; Phorbol Esters; Primary Cell Culture; Protein Domains; Protein Kinase Inhibitors; Pteridines; RNA, Messenger; RNA, Viral; THP-1 Cells; Transcription, Genetic; Virus Activation; Virus Latency; Vorinostat | 2018 |
Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Depsipeptides; Endogenous Retroviruses; Female; Histone Deacetylase Inhibitors; Humans; Imiquimod; Immunity, Innate; Mice, Nude; Ovarian Neoplasms; Pteridines; Signal Transduction; Toll-Like Receptor 7; Tumor Cells, Cultured; Viral Envelope Proteins; Virus Activation; Vorinostat; Xenograft Model Antitumor Assays | 2021 |